February 11, 2022 Comments Off on New patent for Viiv Hlthcare drug APRETUDE Posted in: Patent Added Annual Drug Patent Expirations for APRETUDE Apretude is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Viiv Hlthcare drug APRETUDE appeared first on Dru…
February 11, 2022 Comments Off on New patent for Gilead Sciences drug STRIBILD Posted in: Patent Added Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Gilead Sciences drug STRIBILD appeared first on Dr…
